On-Demand Webinars

  1. Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions 9/10/2024

    Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.

  2. Nanoparticle Enabled Formulation And Drug Delivery Solutions

    Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

  3. The Best CDMO Fit For Small Molecule, Sterile Injectable Fill/Finish 7/19/2023

    "One stop” sterile injectable fill/finish capabilities can accelerate timelines and reduce costs. Explore August Bio’s operational flexibility and available capacity to support small-, mid-size, and large-scale batches.

  4. Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications 6/19/2025

    Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.

  5. Patient- And Planet-Centric Bioavailability And Sustained Delivery

    By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.

  6. Navigating Your Holistic Approach To CCI For Biologic Drug Products 6/12/2024

    Explore regulatory framework and expectations, and see the benefit of a comprehensive approach to CCI tailored for mAbs and complex modalities such as fusion proteins or bioconjugates.

  7. Identify And Mitigate Absorption Risks With PBPK Modeling 3/12/2024

    See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.

  8. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

  9. Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load 8/13/2024

    Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.

  10. Selecting Container Closure Systems With Confidence: Lyophilization 3/7/2024

    Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.